Cancer Detection Test Fails in Major Study

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

20 Feb, 13:35 — 20 Feb, 14:25

Post Share

Perspective Analysis

AI-generated comparison of how 2 sources cover this story

Both the New York Times and Reuters report on a major cancer detection test failing its primary goal in a study. While the New York Times focuses on the medical implications of the test's failure to reduce later-stage disease, Reuters highlights the financial impact, specifically the plunge in shares of Grail. The coverage shows a clear divergence in the primary narrative chosen by each outlet.

What sources agree on

A major cancer detection or screening test failed its main goal.
The failure occurred in a significant study or clinical trial.

Where they diverge

The primary impact or narrative of the story

NYT

The New York Times frames the story around the medical outcome and the test's failure to reduce later stages of cancer.

Reuters

Reuters frames the story around the financial market impact, specifically the plunge in Grail's shares.

Notable gaps

The specific company whose shares were impacted by the test's failure.

Covered by reuters · Not in nytimes

The location of the clinical trial and the specific medical outcome of not reducing later stages of the disease.

Covered by nytimes · Not in reuters

Perspective Analysis

Comparing sources…

Coverage Timeline

Reuters20 Feb, 13:35First to report

Grail shares plunge after major cancer screening trial misses main goal - Reuters

NYT20 Feb, 14:25

A Cancer Detection Test Fails in Major Study

Read at source (2 outlets)

NYT3h ago

A Cancer Detection Test Fails in Major Study

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

By Rebecca Robbins

Read full article →

Reuters4h ago

Grail shares plunge after major cancer screening trial misses main goal - Reuters

Grail shares plunge after major cancer screening trial misses main goal Reuters

Read full article →

PERSPECTA

Cancer Detection Test Fails in Major Study

Perspective Analysis

What sources agree on

Where they diverge

Notable gaps

Perspective Analysis

Coverage Timeline

Grail shares plunge after major cancer screening trial misses main goal - Reuters

A Cancer Detection Test Fails in Major Study

Read at source (2 outlets)

A Cancer Detection Test Fails in Major Study

Grail shares plunge after major cancer screening trial misses main goal - Reuters

Related Stories

NHS Fife Faces Sexism Row Over Inclusive Smear Test Language

NHS Fife Faces Sexism Row Over Smear Test Wording

Mississippi Hospital System Closes Clinics After Ransomware Attack

Dr. Reddy's Biosimilar for Bristol's Orencia Undergoes FDA Review

Perspective Analysis

What sources agree on

Where they diverge

Notable gaps